
2 Ways To Overcome The Challenge Of Developing Neurological Rare Diseases Drugs
By Bruce Leuchter, MD, CEO, GRIN Therapeutics Collectively, neurological rare diseases represent a complex and challenging area of medicine with significant unmet medical need. Drug development for neurological rare diseases can face unique challenges, …